The new Healthcare Minister, David Rath, plans to reduce drug spending by 2% next year; we expect drug expenditures in 2005 to exceed CZK60bn. The reduction should be based on lower reimbursement for individual drugs, hence the Ministry of Health is pushing drug producers to lower their prices. The measure can be potentially positive for Zentiva as it is a domestic generic producer with the lowest prices (on the average). Nevertheless, we are trying to get more information from the company itself.